Medicine and Dentistry
Cohort Analysis
100%
Emergency Department
72%
Lung
49%
Prevalence
26%
Sepsis
25%
Lung Transplantation
25%
Observational Study
24%
Infection
24%
Hazard Ratio
23%
Asthma
22%
All Cause Mortality
22%
Systematic Review
19%
Echography
19%
Case-Control Study
19%
Emergency Care
18%
Comorbidity
17%
Hypotension
14%
Antibiotics
14%
Randomized Controlled Trial
12%
Allograft
12%
Severe Asthma
12%
Montelukast
12%
Charlson Comorbidity Index
12%
Diseases
12%
Creatinine
11%
Health Care
11%
Chronic Kidney Disease
10%
Phlebothrombosis
9%
Single Isomorphous Replacement
9%
Adverse Event
9%
Vital Sign
9%
Silo-Filler's Disease
9%
Cohort Effect
9%
Meta-Analysis
9%
Diabetes
8%
Patient Referral
8%
Sodium Glucose Cotransporter 2 Inhibitor
8%
Scoring System
8%
Bronchodilating Agent
8%
Prognostic Factor
8%
Cardiovascular Disease
7%
Patient Care
7%
Proportional Hazards Model
6%
High-Resolution Computed Tomography
6%
ICD-10
6%
Odds Ratio
6%
Drug Therapy
6%
Idiopathic Pulmonary Fibrosis
6%
Kidney Stone
6%
Asthma Control Questionnaire
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
80%
Asthma
66%
Prevalence
45%
All Cause Mortality
37%
Drug Utilization
34%
Comorbidity
27%
Observational Study
26%
Case-Control Study
25%
Omalizumab
25%
Montelukast
25%
Chronic Kidney Failure
24%
Sepsis
19%
Syndrome
19%
Adverse Event
19%
Dyspnea
16%
Coughing
16%
Thorax Pain
16%
Warfarin
14%
Chronic Obstructive Lung Disease
13%
Mortality Rate
13%
Hypotension
12%
Mepolizumab
12%
Statin (Protein)
11%
Bronchodilating Agent
10%
Infection
10%
Diseases
9%
Kidney Failure
9%
Hospital Mortality
9%
Creatinine
8%
Sodium Glucose Cotransporter 2 Inhibitor
8%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Kidney Disease
8%
Urinary Tract Infection
8%
Cardiovascular Disease
8%
Single Isomorphous Replacement
7%
Antibiotics
7%
Drug-Drug Interaction
7%
Lung Disease
7%
Allergic Asthma
7%
Antihistaminic Agent
7%
Proton Pump Inhibitor
6%
Antivitamin K
6%
Gabapentinoid
6%
Restless Legs Syndrome
6%
Brain Ischemia
6%
Nephrolithiasis
6%
Selective Serotonin Reuptake Inhibitor
6%
D Dimer
6%
Hypoalbuminemia
6%
Albumin
6%
Nursing and Health Professions
Cohort Analysis
40%
Emergency Ward
37%
Confidence Interval
20%
Emergency Care
19%
Prevalence
15%
Infection
13%
Vital Sign
13%
Length of Stay
12%
Echography
12%
Healthcare System
11%
Odds Ratio
9%
Diseases
9%
Hospital Mortality
9%
Charlson Comorbidity Index
8%
Hazard Ratio
8%
Health Care Policy
6%
Teaching Hospital
6%
Body Temperature
6%
Acute Heart Infarction
6%
General Practice
6%
Troponin I
6%
Hypothermia
6%
Systematic Review
6%
Health Care Utilization
6%
Deterioration
6%
Cross-Sectional Study
6%
Lactic Acid
6%
D Dimer
6%
Community Acquired Pneumonia
6%
Hospital Readmission
6%
Patient Care
6%
Community Acquired Infection
6%
Chronic Disease
6%
Sepsis
6%
Patient Referral
6%
Blood Culture
6%
Acute Disease
6%
University Hospital
5%
